Zevra Therapeutics Inc (ZVRA)
8.40
+0.25
(+3.07%)
USD |
NASDAQ |
Nov 01, 16:00
8.405
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Market Cap: 441.99M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 441.99M |
| October 31, 2024 | 428.84M |
| October 30, 2024 | 443.57M |
| October 29, 2024 | 434.62M |
| October 28, 2024 | 423.57M |
| October 25, 2024 | 407.79M |
| October 24, 2024 | 415.68M |
| October 23, 2024 | 421.47M |
| October 22, 2024 | 438.83M |
| October 21, 2024 | 449.36M |
| October 18, 2024 | 446.73M |
| October 17, 2024 | 448.83M |
| October 16, 2024 | 445.15M |
| October 15, 2024 | 440.94M |
| October 14, 2024 | 425.15M |
| October 11, 2024 | 429.36M |
| October 10, 2024 | 416.73M |
| October 09, 2024 | 445.67M |
| October 08, 2024 | 440.41M |
| October 07, 2024 | 409.89M |
| October 04, 2024 | 378.85M |
| October 03, 2024 | 377.80M |
| October 02, 2024 | 374.64M |
| October 01, 2024 | 360.43M |
| September 30, 2024 | 365.17M |
| Date | Value |
|---|---|
| September 27, 2024 | 364.12M |
| September 26, 2024 | 384.64M |
| September 25, 2024 | 397.00M |
| September 24, 2024 | 435.15M |
| September 23, 2024 | 398.84M |
| September 20, 2024 | 424.10M |
| September 19, 2024 | 421.99M |
| September 18, 2024 | 412.00M |
| September 17, 2024 | 396.21M |
| September 16, 2024 | 409.37M |
| September 13, 2024 | 413.05M |
| September 12, 2024 | 399.37M |
| September 11, 2024 | 388.85M |
| September 10, 2024 | 379.90M |
| September 09, 2024 | 380.43M |
| September 06, 2024 | 385.16M |
| September 05, 2024 | 380.43M |
| September 04, 2024 | 378.32M |
| September 03, 2024 | 384.11M |
| August 30, 2024 | 402.53M |
| August 29, 2024 | 388.85M |
| August 28, 2024 | 382.01M |
| August 27, 2024 | 379.37M |
| August 26, 2024 | 372.01M |
| August 23, 2024 | 377.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.387M
Minimum
Mar 18 2020
484.69M
Maximum
Jun 23 2021
184.73M
Average
187.15M
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals Inc | 271.63M |
| BioCardia Inc | 5.076M |
| Xeris Biopharma Holdings Inc | 481.27M |
| Crinetics Pharmaceuticals Inc | 4.537B |
| Instil Bio Inc | 187.18M |
Market Cap Related Metrics
| PS Ratio | 14.00 |
| PEG Ratio | -0.0206 |
| Price to Book Value | 13.61 |
| Price | 8.40 |
| Earnings Yield | -20.00% |
| PEGY Ratio | -0.0206 |